Lawyers’ fees are one of the main causes of complaint by clients and of continued public concern about the ethicality of the profession. Charging ‘fairly and reasonably’ (the legal standard) and in compliance with the detailed legislative requirements imposed on a practitioner can be tricky. Even the most honest and conscientious lawyers may have trouble explaining fees to clients and controlling their increase. Organisational and personal pressures and adversarial approaches can lead to questionable billing practices and place pressure on individual lawyers to behave unethically.

This chapter outlines the fundamental steps common to psychiatric prescribing, from introducing yourself to the patient, to follow-up and documentation. It closes with some critiques of prevalent current practice, which the remainder of the book attempts to address.

Providing care in the perinatal period brings medical practice to the essence of what it means to be human: fertility, birth, death, dignity, personhood, parenthood, and beyond. Such a shifting technological and moral landscape necessitates practitioners to develop an adaptable ethical framework to address complex, emotionally charged, value-laden decisions. As the border of viability is pushed earlier in gestational life and we improve treatment of conditions that were once considered untreatable, areas for ethical inquiry and potential moral distress grow. Our ethical examinations of such advances often lag, evolving as the shortcomings of those leaps become apparent. Projected neurologic function often lies at the heart of ethical questions that emerge in the neonatal period. Despite rigorous efforts in research, reliable, evidence-based guidance is lacking. We must investigate many elements of the decision-making process concerning medical practitioners, families, and the courts. We must balance the rights of the patient and surrogate decision-makers, the duties of the physician and care team, legal precedent, and questions revolving around quality and quantity of life. Recent controversies highlight the challenge of communicating with desperate parents, the delicate balance involved in respecting family preferences today, and research that yields valuable evidence for superior care tomorrow.

This chapter examines how traditional consent frameworks fail to address generative AI systems creating content from personal data. While individuals can consent to initial data use for AI training, they cannot meaningfully consent to the vast array of potential outputs or their subsequent use and distribution. We identify three core challenges creating a "consent gap": the scope problem (inability to predict all possible outputs), the temporality problem (consent cannot cover future unknown uses), and the autonomy trap (consenting to uses that may undermine personal autonomy). These issues are problematic when AI-generated content creates new forms of personal representation beyond original consent boundaries. Current legal frameworks inadequately protect individual autonomy, identity rights, and social responsibility in AI contexts. By connecting these consent limitations to broader responsible AI principles (fairness, transparency, accountability, and autonomy), we argue for evolving ethical and legal approaches that better address generative AI’s challenges to traditional consent models.

JCAHO is the most common organization to assess a hospital. CMS accreditation is basic before reimbursements from Medicare and Medicaid are paid. Annually, new goals are featured but often focus on identification of the patient, preventing infection, labeling drugs, and communication. Available equipment and credentialed staff listed for tasks are both critical, cataloged for each types of resuscitation events, or else accreditation will be lost. The leadership hierarchy must be clear in the hospital for methods to resolve clinical and financial problems. The patient’s bill of rights must be respected and the patient must be given a truly informed consent by the person performing a procedure.

Anosognosia, commonly understood as a lack of insight, renders individuals with schizophreniaand schizoaffective disorder unable to understand that they are living with a disease, often resulting in a refusal to accept treatment. Typically, to impose involuntary commitment in an effort to obtain treatment, an individualmust be a danger to others or themselves. Even if involuntary commitment is imposed, however, an individualmay remain competent to refuse medication—despite symptoms of anosognosia and an inability to understand that they are ill. This article examines the existing legal theories of competency and informed consent and proposes a statutory definition of competency that encompasses the specific needs of people with anosognosia, while considering the significant interests at stake when taking away an individual’s right to choose or refuse treatment.

Medical providers involved in child abuse cases will encounter a variety of issues with legal implications, including informed consent, appropriate documentation, confidentiality, mandated reporting and potential liability. Consequently, all medical providers who may become involved in child abuse cases should have a fundamental understanding of child maltreatment laws in their jurisdiction. While informed consent is a well-established medicolegal doctrine in many countries, there are often jurisdiction-specific variations in cases of suspected child maltreatment. Complete, accurate and objective medical documentation is also imperative, as medical reports are frequently submitted in legal proceedings. Care should be taken, however, to ensure appropriate release and retention of medical records in accordance with country-specific legislation (e.g., Health Insurance Portability and Accountability Act and 21st Century Cures Act in the United States). Finally, medical providers should understand their responsibility to report to the appropriate protective services agency if there is reasonable suspicion that child maltreatment has occurred. A practitioner’s failure to adhere to statutory requirements may result in negative actions against the provider.

This chapter illustrates a challenging clinical ethics case involving a twenty-something trauma patient experiencing dysphagia who declined recommendations for artificial nutrition and wanted to be allowed to take food and fluid by mouth. Capacity assessment was complicated by disagreements over clinical facts. The Ethics consultation process was impacted by limited consultant bandwidth and lack of institutional support. Moral distress was experienced by many team members including clinical ethicists who found themselves wondering how this consult went wrong, and whether withholding food from a decisionally capable patient was in fact within the rights of the healthcare team.

Diagnosing, treating, and caring for individuals with dementia-related syndroms raises unique legal and ethical questions. Individuals with dementia may be more likely to lack decision-making capacity. Additionally, along with their families, individuals with dementia will face complicated health care related decisions – complicated by limited therapy options. This chapter identifies key legal and ethical questions that come up in the clinical and non-clinical setting relevant to dementia-related syndromes.